. "Panick\u00E1 porucha je \u010Dast\u00E9 psychick\u00E9 onemocn\u011Bn\u00ED, kter\u00E9 je charakterizov\u00E1no n\u00E1hl\u00FDmi a ne\u010Dekan\u00FDmi z\u00E1chvaty \u00FAzkosti. Tyto jsou doprov\u00E1zeny masivn\u00EDm strachem nebo d\u011Bsiv\u00FDm o\u010Dek\u00E1v\u00E1n\u00EDm a spojeny s celou \u0159adou t\u011Blesn\u00FDch p\u0159\u00EDznak\u016F. Byla vytvo\u0159ena \u0159ada terapeutick\u00FDch p\u0159\u00EDstup\u016F \u00FA\u010Dinn\u00FDch v l\u00E9\u010Db\u011B panick\u00E9 poruchy. Metodou volby jsou v p\u0159\u00EDpad\u011B farmakoterapie antidepresiva, jinou mo\u017Enost\u00ED je pou\u017Eit\u00ED kognitivn\u011B behavior\u00E1ln\u00ED terapie. Farmakorezistence se objevuje asi u 20?40 % pacient\u016F s panickou poruchou. 70?90 %pacient\u016F, kte\u0159\u00ED podstoup\u00ED terapii pomoc\u00ED kognitivn\u011B behavior\u00E1ln\u00ED terapie, popisuje zlep\u0161en\u00ED. P\u0159ibli\u017En\u011B 10?49 % pacient\u016F z\u016Fst\u00E1v\u00E1 rezistentn\u00EDch na l\u00E9\u010Dbu i p\u0159i pou\u017Eit\u00ED optim\u00E1ln\u00ED farmakoterapie a kognitivn\u011B behavior\u00E1ln\u00ED terapie, a to i p\u0159i u\u017Eit\u00ED augmenta\u010Dn\u00EDch strategi\u00ED s anxiolytiky,antipsychotiky nebo serotoninergn\u00EDmi l\u00E1tkami." . "Panic disorder and pharmacoresistance"@en . "15" . . "7"^^ . . . "P(NS10301)" . . "combination; augmentation; pharmacoresistance; benzodiazepines; antidepressants; cognitive behavioral therapy; panic disorder"@en . . . "Panick\u00E1 porucha a farmakorezistence"@cs . . . "15110" . "Panick\u00E1 porucha a farmakorezistence"@cs . . . "Panic disorder and pharmacoresistance"@en . . "Postgradu\u00E1ln\u00ED medic\u00EDna" . . . "Panick\u00E1 porucha a farmakorezistence" . "L\u00E1talov\u00E1, Kl\u00E1ra" . "4"^^ . "Panic disorder is frequent psychiatric disorder characterized by sudden and unexpected onset of a panic attack, characterized by terror or impending doom, and associated with many somatic symptoms. Effective treatments for panic disorder are available. The treatment of choice is pharmacotherapy with antidepressants or cognitive behavioral therapy. Pharmacoresistance occurs in 20% to 40% of patients with panic disorder. 70% to 90% of patients who undergo treatment with cognitive behavioral therapy report improvement. Approximately 10% to 49% of patients remain treatment resistant to optimal pharmacotherapy and cognitive behavioral therapy, even when using augmentation strategies with anxiolytics, antipsychotics or serotonergic agents."@en . "CZ - \u010Cesk\u00E1 republika" . . "1212-4184" . . "Panick\u00E1 porucha je \u010Dast\u00E9 psychick\u00E9 onemocn\u011Bn\u00ED, kter\u00E9 je charakterizov\u00E1no n\u00E1hl\u00FDmi a ne\u010Dekan\u00FDmi z\u00E1chvaty \u00FAzkosti. Tyto jsou doprov\u00E1zeny masivn\u00EDm strachem nebo d\u011Bsiv\u00FDm o\u010Dek\u00E1v\u00E1n\u00EDm a spojeny s celou \u0159adou t\u011Blesn\u00FDch p\u0159\u00EDznak\u016F. Byla vytvo\u0159ena \u0159ada terapeutick\u00FDch p\u0159\u00EDstup\u016F \u00FA\u010Dinn\u00FDch v l\u00E9\u010Db\u011B panick\u00E9 poruchy. Metodou volby jsou v p\u0159\u00EDpad\u011B farmakoterapie antidepresiva, jinou mo\u017Enost\u00ED je pou\u017Eit\u00ED kognitivn\u011B behavior\u00E1ln\u00ED terapie. Farmakorezistence se objevuje asi u 20?40 % pacient\u016F s panickou poruchou. 70?90 %pacient\u016F, kte\u0159\u00ED podstoup\u00ED terapii pomoc\u00ED kognitivn\u011B behavior\u00E1ln\u00ED terapie, popisuje zlep\u0161en\u00ED. P\u0159ibli\u017En\u011B 10?49 % pacient\u016F z\u016Fst\u00E1v\u00E1 rezistentn\u00EDch na l\u00E9\u010Dbu i p\u0159i pou\u017Eit\u00ED optim\u00E1ln\u00ED farmakoterapie a kognitivn\u011B behavior\u00E1ln\u00ED terapie, a to i p\u0159i u\u017Eit\u00ED augmenta\u010Dn\u00EDch strategi\u00ED s anxiolytiky,antipsychotiky nebo serotoninergn\u00EDmi l\u00E1tkami."@cs . "3"^^ . "1" . . "RIV/61989592:15110/13:33143453" . . . . "Kamar\u00E1dov\u00E1, Dana" . "Grambal, Ale\u0161" . . "[5DD527E29C69]" . . "95232" . "Pra\u0161ko Pavlov, J\u00E1n" . "RIV/61989592:15110/13:33143453!RIV14-MZ0-15110___" . "Panick\u00E1 porucha a farmakorezistence" .